Compare · ELV vs PMD
ELV vs PMD
Side-by-side comparison of Elevance Health Inc. (ELV) and Psychemedics Corporation (PMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and PMD operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $81.91B, about 2049.8x PMD ($40.0M).
- ELV has hit the wire 6 times in the past 4 weeks while PMD has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 0 for PMD).
- Company
- Elevance Health Inc.
- Psychemedics Corporation
- Price
- -
- -
- Market cap
- $81.91B
- $40.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 0
- Recent ratings
- 23
- 0
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Psychemedics Corporation
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest PMD
- Psychemedics Releases 2026 Education Insights Report
- Psychemedics Releases 2026 Workforce Insights Report
- Psychemedics Releases 2025 Workforce Insights Report
- Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights
- SEC Form 15-12G filed by Psychemedics Corporation
- Large owner Powell Anderson Capital Partners Llc bought $305,439 worth of shares (159,700 units at $1.91) (SEC Form 4)
- SEC Form 25 filed by Psychemedics Corporation
- Large owner Powell Anderson Capital Partners Llc bought $231,849 worth of shares (86,991 units at $2.67) (SEC Form 4)
- Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation
- Director Kamin Peter sold $753,664 worth of shares (320,708 units at $2.35) (SEC Form 4)